Huge news: Airlines will no longer be allowed to charge for hand luggage in Europe
The proposal will allow holidaymakers to travel with carry-on luggage up to 7 kilograms with no extra fee – and that's on top of your under-the-seat backpack, too.
According to the European Parliament's press release, vice-president of the EU Committee on Transport and Tourism Matteo Ricci said the move 'marks an important step toward fairer and more transparent travel' and will 'introduce concrete measures such as the clear definition of free hand luggage up to a maximum size of 100cm, a fundamental right to avoid unjustified extra costs.'
Obviously, this is a massive win for travellers, but not everyone's happy about it. It's expected to hit low-cost airlines particularly hard – Ryanair, for example, made €4.7 billion last year from charging extra fees like seat selection and baggage costs.
While airline lobbies have warned that the ruling could mean carriers will end up increasing their ticket prices to make up for the costs, the ruling is part of wider reforms proposed by the European Parliament on passenger rights.
Further measures include allowing children under 12 to sit with their accompanying passenger free of charge, granting free seats to carers of people with reduced mobility, and forcing airlines to disclose the full cost of flights upfront.
All in all, this is very good news for passengers. It's not clear when the ruling will kick in, as the proposals still need to get the final green light in a parliamentary vote. Keep an eye on this page for further details.
Our travel news hub has all the latest on air travel news, from the Qatar airspace closure this week to airline and airport strikes across Europe and the winners of the latest World Airline Awards.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
5 minutes ago
- Leader Live
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs cap of 15%
Taoiseach Micheal Martin said the trade agreement represented a 'significant win' for the EU while Tanaiste Simon Harris said it offered an 'important shield' for Irish exporters. The EU struck a trade deal with the US on July 27, five days before Mr Trump said a 30% tariff would kick in for the bloc. The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US. There are 'zero for zero' tariffs on a number of products including aircrafts and aircraft parts, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years. In the aftermath of the deal, it was not clear whether 15% would remain the rate for the pharma sector or be increased. The EU-US statement published on Thursday said that as of September 1, the US will apply a maximum tariff rate of 15% on generic pharmaceuticals, their ingredients and chemical precursors. 'The United States intends to promptly ensure that the tariff rate, comprised of the MFN (Most Favored Nation) tariff and the tariff imposed pursuant to Section 232 of the Trade Expansion Act of 1962, applied to originating goods of the European Union subject to Section 232 actions on pharmaceuticals, semiconductors, and lumber does not exceed 15%.' Mr Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the assurances for the pharmaceutical and semiconductor sectors. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the EU-US agreement would mean in practice. 'This is especially important for enterprises that either import from or export to the US,' he said. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.' Paul Sweetman, chief executive of the American Chamber of Commerce Ireland, welcomed the joint statement as providing 'greater clarity to business on the future of the transatlantic trading partnership, worth over four billion dollars daily'. 'The framework brings more certainty and allows for further work to grow our mutually beneficial economic relationship,' he said. 'In supporting the US-Ireland and US-EU trading relationships into the future, we must also focus on enhancing competitiveness. 'Now is the time to make smart policy and investment decisions to deliver critical infrastructure projects, meet future skills needs, bolster our RD&I ecosystem, and secure Ireland's position as a digital regulatory hub. 'AmCham will continue to work closely with the Irish Government, the US administration and our EU and US partners in growing investment on both sides of the Atlantic.'
Powys County Times
5 minutes ago
- Powys County Times
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs cap of 15%
Ireland's premier and deputy premier have welcomed clarity on the EU-US trade deal, which sees the US commit to capping tariffs on pharma goods at 15%. Taoiseach Micheal Martin said the trade agreement represented a 'significant win' for the EU while Tanaiste Simon Harris said it offered an 'important shield' for Irish exporters. The EU struck a trade deal with the US on July 27, five days before Mr Trump said a 30% tariff would kick in for the bloc. The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US. There are 'zero for zero' tariffs on a number of products including aircrafts and aircraft parts, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years. In the aftermath of the deal, it was not clear whether 15% would remain the rate for the pharma sector or be increased. The EU-US statement published on Thursday said that as of September 1, the US will apply a maximum tariff rate of 15% on generic pharmaceuticals, their ingredients and chemical precursors. 'The United States intends to promptly ensure that the tariff rate, comprised of the MFN (Most Favored Nation) tariff and the tariff imposed pursuant to Section 232 of the Trade Expansion Act of 1962, applied to originating goods of the European Union subject to Section 232 actions on pharmaceuticals, semiconductors, and lumber does not exceed 15%.' Mr Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the assurances for the pharmaceutical and semiconductor sectors. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the EU-US agreement would mean in practice. 'This is especially important for enterprises that either import from or export to the US,' he said. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.' Paul Sweetman, chief executive of the American Chamber of Commerce Ireland, welcomed the joint statement as providing 'greater clarity to business on the future of the transatlantic trading partnership, worth over four billion dollars daily'. 'The framework brings more certainty and allows for further work to grow our mutually beneficial economic relationship,' he said. 'In supporting the US-Ireland and US-EU trading relationships into the future, we must also focus on enhancing competitiveness. 'Now is the time to make smart policy and investment decisions to deliver critical infrastructure projects, meet future skills needs, bolster our RD&I ecosystem, and secure Ireland's position as a digital regulatory hub. 'AmCham will continue to work closely with the Irish Government, the US administration and our EU and US partners in growing investment on both sides of the Atlantic.'
The Herald Scotland
18 minutes ago
- The Herald Scotland
Jakob Breum to Celtic update with club set on £6m valuation
Wednesday's goalless draw with Kairat Almaty left hopes of advancing from the play-off round in the balance. Chants of 'Sack The Board' rang out the stadium as supporters voiced their frustration over a lack of quality signings. One report claims Celtic have ramped up their pursuit of the playmaker by holding fresh talks with Go Ahead chiefs over an agreement. We understand that is NOT the case and that the last contact between the two parties was last month. In the market for wide players after selling Nicholas Kuhn to Como for £17m and losing the services of the injured Jota until early next year, the Parkhead club opened with £1.5million last month. Despite Celtic upping their original proposal to £1.75million plus add-ons, then putting £3million on the table, the Dutch Cup holders want £5million plus another £1million in bonus payments if Celtic reach the Champions League. Preparing to compete in the group stages of the Europa League after beating AZ in last season's KNVB Cup Final, Go Ahead fear a late scramble to secure a late Breum replacement. Read more: Unwilling to budge on their initial valuation the price is likely to increase if Brendan Rodgers's side overcome their sluggish performance in Glasgow to overcome Kairat and take their place alongside the European elite. PSV placed Breum high on their shortlist of summer signings before deciding to pay £15million for AZ's Ruben van Bommel instead. Claiming their valuation is fair and realistic senior figures inside Go Ahead have told Celtic to take or leave their valuation. Celtic plan to wrap up a £4.5million move for Antwerp's Belgian winger Michel-Ange Balikwisha, with obstacles at the player's end delaying a final agreement. It remains to be seen whether the capture of Balikwisha might end any lingering interest in Breum.
